Harry Sutton | Post-doctoral Fellow, Center for Infectious Disease and Vaccine Research,
La Jolla Institute for Allergy and Immunology

WVIC/WAC Pre-Congress Workshops - Nov 28 @ 14:00

Workshop A [Room: Constellation A]

2pm: Chair opening remarks: Rebecca Kurnat M.S., Head of Product, SaponiQx

Presentations: 2.10pm – 4.00pm:

Using synthetic biology in adjuvant technology & creating a pipeline of vaccine adjuvants

Dr John Baldoni, Head of Science, SaponiQx

Next generation TLR agonists & RIG-I as adjuvants

Dr Steve Reed, CEO, HDT Bio

An oral adjuvant to augment vaccine effectiveness

Dr Upendra Marathi, President & CEO, 7Hills Pharma

Long-lasting germinal center responses to a priming immunization with continuous proliferation and somatic mutation

Dr Harry Sutton, Post-doctoral Fellow, Center for Infectious Disease and Vaccine Research, LaJolla Institute for Immunology

4.00-5:00pm Q&A and Panel Discussion with all speakers

• What are the limitations of current adjuvants?
• Importance of unique formulations & combination adjuvants
  • Kinetics, localization, dose sparing
• Ensuring a secure supply of known adjuvants
  • Rapid response and stockpiling
• Emerging concepts in adjuvant science
• What mechanisms are required to advance vaccines?
• Novel adjuvant technology – synthetic adjuvants
• Development of an adjuvant pipeline – can new adjuvants rescue previously failed vaccines?
• What factors drive clinical failure?

Rebecca Kurnat M.S., Head of Product, Saponiqx

×

Rebecca Kurnat M.S. / Workshop A [Room: Constellation A]

Rebecca Kurnat M.S., Head of Product,
Saponiqx

Executive with the ability to provide strategic leadership across all phases of drug development based upon 20 years’ experience managing large, technically complex, programs and product portfolios, with increasing influence from academia through private industry, in pursuit of Food and Drug...

CloseMore

Steven Reed, Chief Executive Officer, HDT Bio Corp

×

Steven Reed / Workshop A [Room: Constellation A]

Steven Reed, Chief Executive Officer,
HDT Bio Corp

Steve Reed is the co-founder, President, and CEO of HDT Bio, based in Seattle, USA. His academic appointments include Adjunct Professor of Medicine at Cornell University Medical College Research Professor of Pathobiology at the University of Washington. Dr. Reed received a PhD in Microbiology and...

CloseMore

Upendra Marathi, Chief Executive Officer, 7 Hills Pharma LLC

×

Upendra Marathi / Workshop A [Room: Constellation A]

Upendra Marathi, Chief Executive Officer,
7 Hills Pharma LLC

Upendra Marathi, PhD, MBA is the CEO and a co-founder of 7 Hills Pharma.  He is an inventor of their first-in-concept technology and a significant investor in the company. He has led the development of three novel pain and cardiovascular drugs, including one recently approved by the FDA. He...

CloseMore

John Baldoni, Head of Science, Saponiqx

×

John Baldoni / Workshop A [Room: Constellation A]

John Baldoni, Head of Science,
Saponiqx

Dr. John Baldoni has developed an expansive portfolio over 40+ years in the pharmaceutical industry. His previous positions include Senior Vice President of Drug Discovery, and Senior Vice President of Platform Technology and Science (PTS) at GSK Pharma R&D. His experience spans chemical entity ...

CloseMore

Harry Sutton, Post-doctoral Fellow, Center for Infectious Disease and Vaccine Research,, La Jolla Institute for Allergy and Immunology

×

Harry Sutton / Workshop A [Room: Constellation A]

Harry Sutton, Post-doctoral Fellow, Center for Infectious Disease and Vaccine Research,,
La Jolla Institute for Allergy and Immunology

Harry Sutton is Post-doctoral Scholar in the Crotty lab at the La Jolla Institute for Immunology. He completed his PhD in 2021 at the John Curtin School of Medical Research in Canberra, Australia. His primary research interests have been studying how B cells respond to vaccine targets of infectious ...

CloseMore